000 | 01023 a2200325 4500 | ||
---|---|---|---|
005 | 20250513085931.0 | ||
264 | 0 | _c19960523 | |
008 | 199605s 0 0 eng d | ||
022 | _a1046-9516 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDavis, T P | |
245 | 0 | 0 |
_aConformationally constrained peptide drugs targeted at the blood-brain barrier. _h[electronic resource] |
260 |
_bNIDA research monograph _c1995 |
||
300 |
_a47-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 | _aBlood-Brain Barrier |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aPeptides _xpharmacokinetics |
650 | 0 | 4 | _aPermeability |
650 | 0 | 4 | _aProtein Conformation |
650 | 0 | 4 | _aSolubility |
700 | 1 | _aAbbruscato, T J | |
700 | 1 | _aBrownson, E | |
700 | 1 | _aHruby, V J | |
773 | 0 |
_tNIDA research monograph _gvol. 154 _gp. 47-60 |
|
999 |
_c8605797 _d8605797 |